EBOLA Act
- Sponsor
- Sen. Shaheen, Jeanne [D-NH]
- Committees
- Foreign Relations Committee (primary)
- Last action
- Jun 24, 2026
Bottom line
This bill compels the U.S. to re-engage with the World Health Organization to address global health crises, particularly the ongoing Ebola outbreak, by restoring membership and funding.
What it actually does
This bill mandates the United States to rejoin the World Health Organization within 30 days of its enactment, reversing a previous withdrawal. It also requires immediate collaboration with the WHO to combat the 2026 Ebola Disease outbreak in Central and Eastern Africa and authorizes appropriations for both membership fees and response efforts.
Proponents argue
Proponents argue that continued U.S. participation in the WHO is crucial for national security, public health, and economic well-being, especially given the rapid spread of the 2026 Ebola outbreak. They contend that the WHO is the principal international body for disease surveillance and response, and U.S. re-engagement is essential for effective global coordination and preventing the spread of infectious diseases to American territory.
Opponents contend
Opponents of rejoining the WHO, consistent with the rationale for the previous withdrawal, would likely argue that the organization requires significant reforms and that U.S. funds could be better utilized through bilateral aid or other mechanisms that offer greater direct control and accountability. They might express concerns about the WHO's effectiveness, transparency, or perceived bias, suggesting that rejoining without fundamental changes would be a waste of taxpayer money.
The bill is very short and straightforward, making it easily accessible for any reader to understand its core provisions.
Section 3(1)
Mandate to Rejoin the World Health Organization
This provision requires the President, in coordination with the Secretary of State, to take all necessary steps for the United States to rejoin the World Health Organization within 30 days of the bill's enactment. This action reverses the previous administration's withdrawal from the international health body, aiming to restore U.S. formal engagement in global health governance.
Supporters argue
Supporters argue that rejoining the WHO is critical for restoring U.S. leadership in global health, enabling better coordination during pandemics, and ensuring access to vital international disease surveillance data. They believe it's essential for protecting American public health interests.
Critics contend
Critics, consistent with the rationale for the previous withdrawal, might argue that the WHO is flawed and requires significant reforms before the U.S. should recommit. They may contend that rejoining without such reforms would legitimize an inefficient or compromised organization.
Tradeoffs
The provision balances the desire for U.S. global health leadership and coordination against concerns about the WHO's effectiveness and accountability.
Section 3(2)
Immediate Collaboration on Ebola Outbreak
This provision directs the President and Secretary of State to immediately collaborate with the World Health Organization to respond to the ongoing 2026 Ebola Disease outbreak in Central and Eastern Africa. This ensures a rapid and coordinated U.S. response to a critical global health emergency, aiming to contain the virus's spread.
Section 4
Funding Authorization for WHO Membership and Ebola Response
This section authorizes the appropriation of "such sums as may be necessary" to cover the financial obligations of restoring U.S. membership in the WHO, including assessed contributions. It also authorizes funding to support the WHO and other UN entities' efforts to respond to the Ebola epidemic in Central and Eastern Africa, through voluntary contributions and programmatic support, to prevent global transmission.